Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fosun Named One of China’s Top Ten Innovative Pharmas

publication date: Jun 28, 2013
Shanghai Fosun Pharma was one of ten pharmas listed as “China’s Most Innovative Pharmaceutical Enterprises.” In announcing the award, Fosun emphasized its internal research, mentioning that its malaria treatment was recently accepted by WHO and that a clinical trial of its transdermal patch for Parkinson’s Disease was approved by the CFDA. Both of these are worthy accomplishments, especially for an award that stresses innovation, but much of Fosun’s growth over the years has been a result of the company’s relentless R&D activity. More details....

Stock Symbol: (SHA: 600196: HK: 02196)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital